about
Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia modelRituximab is not a "magic drug" in post-transplant recurrence of nephrotic syndrome.Significant changes in the composition of the precursor B-cell compartment in children less than 2 years old.Nijmegen Breakage Syndrome: Clinical and Immunological Features, Long-Term Outcome and Treatment Options - a Retrospective Analysis.The defect in humoral immunity in patients with Nijmegen breakage syndrome is explained by defects in peripheral B lymphocyte maturation.B cell subsets in healthy children: reference values for evaluation of B cell maturation process in peripheral blood.Clinical immunology Disseminated Mycobacterium tuberculosis complex infection in a girl with partial dominant IFN-γ receptor 1 deficiencyImmunological factors and liver fibrosis in pediatric liver transplant recipientsCombined Liver-Kidney Transplantation in Children: Single-Center Experiences and Long-Term ResultsThe significance of anti-HLA antibody presence in children who lost the transplanted kidney due to vascular thrombosisPresence of IgG anti-HLA antibodies in fourteen patients after cryopreserved allogenic heart valve implantationEarly cytokine production in response to cryopreserved heart valve implantation in pediatric recipientsLong-term effect of rituximab in maintaining remission of recurrent and plasmapheresis-dependent nephrotic syndrome post-renal transplantation - case reportChronic rhinosinusitis in primary antibody immunodeficient patientsAntibody-mediated rejection in pediatric liver transplant recipients
P50
Q34117470-464F4A85-FDEA-46C3-9CC6-92F8E2EB72A1Q37218346-57ADE44E-D497-4693-A28D-3063352B3EC5Q39454415-BF368553-B2CF-47AA-8226-F1B1C4618144Q41053811-F6218879-39E8-4DD1-8768-57D34317589AQ50944636-5DCE8261-1D63-4DC9-991F-FB822EEA6130Q51051104-3A4E5962-843B-45F2-9162-47BB95CFB05FQ56939750-8670F5B9-78AE-416F-8FC9-189A2D406D00Q57144948-6CF38270-E7D2-4C04-A670-687F0847F4A8Q59353361-77558FD5-2522-46E4-B6D1-FE289FE8744BQ74094232-6BECF932-D972-463C-A6AB-1B9327E1F458Q74094358-F21F5899-A346-4FB1-B75D-E499D736B800Q78693626-BF42E90A-6B4E-49ED-A345-EC9ABD29A9D1Q83888240-9B7D1E6C-91A5-4E78-829A-3DEA1A063E75Q83993833-369C88D2-AF0A-4ACA-98BF-AD521A6A90BEQ87401842-79F66D79-C772-4338-A0A3-3D27214CB71C
P50
description
researcher ORCID ID = 0000-0001-8949-047X
@en
wetenschapper
@nl
name
Barbara Piątosa
@ast
Barbara Piątosa
@en
Barbara Piątosa
@es
Barbara Piątosa
@nl
type
label
Barbara Piątosa
@ast
Barbara Piątosa
@en
Barbara Piątosa
@es
Barbara Piątosa
@nl
prefLabel
Barbara Piątosa
@ast
Barbara Piątosa
@en
Barbara Piątosa
@es
Barbara Piątosa
@nl
P214
P1153
6602630747
P21
P214
P31
P496
0000-0001-8949-047X
P735
P7859
viaf-311811104